Home › Trial NCT03561272
The Validation of a Novel Adherence Method for Oral Oncolytics
- Trial IDNCT03561272
- StatusCompleted
- PhaseN/A
- Study typeInterventional
- SponsorUniversity of Michigan Rogel Cancer Center
- Enrollment18
- Start date2017-06-20
- ConditionsCancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.